ABSTRACT Background: Epidemiologic studies have yielded inconsistent findings between breastfeeding and epithelial ovarian cancer (EOC) risk.
INTRODUCTION
Epithelial ovarian cancer (EOC) is the second most-common cause of gynecologic cancer mortality worldwide, which accounted for almost 4.2% of all female cancer deaths in 2008 (1) . Because EOC is often diagnosed at an advanced stage, has a poor prognosis with an overall 5-y survival rate of just 45% (2) , and early detection efforts have not yet been successful (3), the identification of modifiable risk factors is necessary to reduce the burden of disease (4) .
Two well-established risk factors for EOC [ie, the use of oral contraceptives (OCs) and parity] have been hypothesized to decrease risk by suppressing ovulation, which has been explained by the ''incessant ovulation'' hypothesis (5) or related to decreasing gonadotropin concentrations (6) (7) (8) . Our recent metaanalysis (9) supported this hypothesis because later menarcheal age was inversely associated with EOC risk. Breastfeeding also causes gonadotrophin suppression. This suppression leads to low estrogen concentrations and anovulation with a resulting period of lactational amenorrhea and, therefore, has been investigated as a potential factor related to EOC development (10) .
A report from the World Cancer Research Fund identified breastfeeding as "limited suggestive" for protection from EOC (11) . Although a collaborative pooled analysis of 12 casecontrol studies in North America showed an inverse relation between ever breastfeeding and EOC risk (7) , several prospective cohort studies have shown no association (12, 13) . Analyses by histologic subtypes also showed conflicting results (14) (15) (16) . Moreover, findings on the protective role of a longer duration of breastfeeding have been still inconsistent in recent studies (4, 14, 16, 17) . A previous meta-analysis that included 15 case-control studies from developed countries published through 2005 was done by Ip et al (18) and was published in 2009, which showed a significant inverse association between ever breastfeeding and EOC risk. Since this meta-analysis, several relevant studies, including prospectively designed studies on the association between breastfeeding and EOC risk, have been published. Therefore, we conducted a meta-analysis of all observational studies published up to December 2012 to summarize available evidence on the association between both ever breastfeeding and breastfeeding duration with risk of EOC.
METHODS

Literature search
We performed a comprehensively literature search including published studies from database initiation until December 31, 2012 with the use of MEDLINE (PubMed; http://www.ncbi.nlm. nih.gov/pubmed). The search was limited to published studies in English and studies of humans by using the following search key words and Medical Subject Headings terms: (breastfeeding OR breast feed OR lactation OR infant nutrition OR breast milk OR milk human) AND (ovary OR ovarian) AND (cancer OR neoplasm OR carcinoma OR tumor). We also reviewed references of all included studies for additional publications. We followed standard criteria for conducting and reporting meta-analyses (19, 20) .
Study selection
To be included, studies had to use a case-control or cohort study design and investigate the association between ever breastfeeding or the total duration of breastfeeding and incident EOC. The publication had to present the HR, OR, or RR with 95% CIs or data necessary to calculate these. When multiple publications from the same study were available, we used the publication with the largest number of cases and most-applicable information. We identified 35 potentially relevant full-text publications (4, (12) (13) (14) (15) (16) (17) from 6892 articles ( Figure 1 ). Four publications (46) (47) (48) (49) only reported the longest compared with shortest categories of total duration of breastfeeding and were, therefore, only included in the breastfeeding duration and dose-response analysis. For the cancer histology subgroup analysis, we included 2 publications (50, 51) that were duplicate reports from an alreadyrepresented study population but reported information on EOC histology.
Data abstraction
For each eligible study, 2 investigators (T-TG and Q-JW) independently performed the eligibility evaluation and data abstraction.
Disagreements were discussed and resolved by consensus. Data abstracted from each study were as follows: author list, year of publication, study region and design, study sample size (number of cases and controls or cohort size), range of follow-up for cohort studies, exposure and outcome assessment including ever breastfeeding and the total or average breastfeeding-duration categories, study-specific adjusted estimates with their 95% CIs for ever compared with never breastfeeding and longest compared with shortest of the total or average duration category of breastfeeding, and factors matched by or adjusted for in the design or data analysis. If multiple estimates of the association were available, we abstracted the estimate that adjusted for the most covariates. If no adjusted estimates were presented, we included the crude estimate. If no estimate was presented in a given study, we calculated it and its 95% CI according to the raw data presented in the article.
We did not use the Newcastle-Ottawa Scale (9, 52, 53) to assess the methodologic quality of all included studies because quality scoring in a meta-analysis of observational studies is controversial, lacks demonstrated validity, and sometimes results may not be associated with quality (54, 55) . Instead, we carried out numerous subgroup and sensitivity analyses.
Statistical analysis
Study-specific adjusted RRs were used as measures of the association across studies. Because absolute risk of EOC is low, we assumed that estimates of ORs from case-control studies and risk, rate, or HRs from cohort studies were all valid estimates of the RR, and therefore, we reported all results as the RR for simplicity (9) . For studies that did not use the category with the shortest-duration breastfeeding as the reference, we used the effective-count method proposed by Hamling et al (56) to recalculate RRs.
For the dose-response analysis, we used the method proposed by Greenland et al (57) and Orsini et al (58) to compute studyspecific slopes (linear trends) and 95% CIs from the ln of RRs and FIGURE 1. Selection of studies for inclusion in the meta-analysis. CIs across categories of the total duration of breastfeeding. The method requires that the distribution of cases and person-years of noncases and RRs with the variance estimates for $3 quantitative exposure categories are known. For studies that reported the duration by ranges, we estimated the midpoint in each category by calculating the average of the lower and upper bounds. When the highest category did not have an upper bound, we assumed the length of the open-ended interval to be the same as that of the adjacent interval. When the lowest category did not have a lower bound, we set the lower bound to zero. Dose-response results in forest plots are presented on the basis of 5-mo increments for the total duration of breastfeeding.
We evaluated the heterogeneity of RRs across studies by using the Cochrane Q statistic, where P , 0.1 was indicative of statistically significant heterogeneity, and I 2 statistic. The summary estimate was based on the fixed-effects model (59) for no detected heterogeneity or the random-effects model (60) when substantial heterogeneity was detected. In both methods, the weight of each study depended on the inverse of the variance of log OR, which was estimated by the 95% CI from each study. Because limited studies (14, 16, 17, 23, 25, 30, 36, 39, 46) reported results of the average duration of breastfeeding per child, summary estimates were calculated for ever breastfeeding and the total duration of breastfeeding. Subgroup analyses were carried out based on the study design (cohort compared with case-control studies), type of controls within case-control studies (population-based compared with hospital-based controls), exposure assessment (self-administered questionnaire compared with trained interviewers), geographic location (Europe, America, and Asia), cancer grading (invasive compared with borderline), and cancer histotype (serous, mucinous, endometrioid, and clear cell). We also stratified the meta-analysis by potentially important confounders (ie, parity, BMI, OC use, and smoking status). Heterogeneity between subgroups was evaluated by using a meta-regression. Finally, we carried out sensitivity analyses by excluding one study at a time to explore whether results were strongly influenced by a specific study. Publication bias was evaluated via Egger's linear regression (61), Begg's rank-correlation methods (62) , and funnel plots. P , 0.05 for Egger's or Begg's tests was considered representative of a significant statistical publication bias. Statistical analyses were performed with Stata software (version 11.2; StataCorp). P values were 2 sided with a significance level of 0.05.
RESULTS
Study characteristics
Characteristics of the 35 included articles are shown in Table  1 . The included articles, which represented 14,465 cases and 706,152 noncases, were published between 1983 and 2012 and consist of 5 cohort studies (4, 12, 13, 21, 22) and 30 case-control studies (14-17, 23-45, 47-49) . All of the studies only included parous women in analyses. Of the 5 cohort studies, 2 studies each were conducted in the United States (4, 13) and Europe (21, 22) , and one study was conducted in Japan (12) . Cohort sizes ranged from 3319 (22) to 327,396 (21) , and the number of EOC cases varied from 86 (12) to 878 (21) cases. The longest total duration of breastfeeding varied from 13 mo (21) to .24 mo (22) . The shortest total duration of breastfeeding varied from never (4, 22) to ,1 mo (21).
Of 30 case-control studies, 12 studies were conducted in the United States (17, 23, 24, 27, 28, 30, 34, 41, 43, 45, 48, 49) , 3 studies were conducted in China (29, 31, 40) , 3 studies were conducted in Japan (36, 37, 44) , 2 studies each were conducted in Australia (14, 38) , Sweden (32, 47) , and Italy (16, 33) , and one study each was conducted in Denmark (15) , Poland (26) , the United Kingdom (42) , and Mexico (35) . Two studies covered multiple countries (25, 39) . The number of cases enrolled in these studies ranged from 84 (35) to 1092 (14) cases, and the number of control subjects varied from 150 (26) to 25,488 (36) subjects. Control subjects were drawn from the general population in 18 studies (14, 15, 17, 23-25, 27, 28, 30, 32, 34, 38, 40, 41, 45, 47-49) , hospitals in 11 studies (16, 26, 31, 33, 35-37, 39, 42-44) , and both places in one study (29) . The longest total duration of breastfeeding varied from 9 mo (48) to .48 mo (39) . The shortest total duration of breastfeeding varied from never (14-17, 23-28, 30-36, 38, 40-43) to ,24 mo (49).
Breastfeeding
Five cohort (4, 12, 13, 21, 22, 48) and 27 case-control (14) (15) (16) (17) studies investigated the association between ever breastfeeding and EOC risk. The summary RR of EOC for the ever compared with never categories of breastfeeding was 0.76 (95% CI: 0.69, 0.83) with moderate heterogeneity (Q = 69.4, P , 0.001, I 2 = 55.3%) (Table 2, Figure 2 ). There was no indication of a publication bias by using Egger's test (P-bias = 0.495) or Begg's test (P-bias = 0.538), and no asymmetry was observed in funnel plots when inspected visually.
Longest compared with shortest total durations of breastfeeding
Four case-control studies (17, 25, 36, 63) reported the average duration of breastfeeding, and these studies were excluded from FIGURE 2. Forest plot (random-effects model) of ever breastfeeding and ovarian cancer risk. Squares indicate study-specific RRs (the size of the square reflects the study-specific statistical weight); horizontal lines indicate 95% CIs; the diamond indicates the summary RR estimate with its 95% CI. the analysis. Three cohort (4, 21, 22 ) and 23 case-control (14-16, 23, 24, 26-29, 31-35, 38-43, 47-49) studies investigated the association between the total duration of breastfeeding and EOC risk. The summary RR of EOC for the longest compared with shortest total duration categories of breastfeeding was 0.65 (95% CI: 0.55, 0.78) with significant heterogeneity (Q = 70.26, P , 0.001, I 2 = 64.4%) ( Table 3) . There was no indication of a publication bias by using Egger's test (P-bias = 0.068) or Begg's test (P-bias = 0.741), and no asymmetry was seen in funnel plots when inspected visually.
Dose-response analysis of total duration of breastfeeding
Three cohort (4, 21, 22) and 22 case-control (14-16, 23, 24, 26-28, 31-35, 38-43, 46-48) studies were included in the doseresponse analysis. The summary RR for each increase by 5 mo for breastfeeding duration was 0.92 (95% CI: 0.90, 0.95) with significant heterogeneity (Q = 74.12, P , 0.021, I 2 = 67.6%) (Table 4, Figure 3 ). Publication bias was not evident by using Egger's test (P = 0.090) or Begg's test (P = 0.161) or by visual inspection of the funnel plot.
Subgroup and sensitivity analyses
In subgroup analyses of ever breastfeeding and EOC risk, all strata showed inverse associations, and there was no evidence of significant heterogeneity between subgroups with meta-regression analyses (Table 2) . Similar results were also observed in doseresponse analyses of the relation between the total duration of breastfeeding and EOC risk (Table 4) . We further focused on the difference between studies in which associations with breastfeeding were of primary interest (4, 14-17, 21-25, 29, 30, 34, 35, 38, 39, 41, 44-46, 48, 49) and studies that mainly dealt with other associations (12, 13, 26-28, 31-33, 36, 37, 40, 42, 43, 47) . However, results of the meta-regression and tests for heterogeneity did not show a significant difference in the analyses of ever breastfeeding or in breastfeeding duration (data not shown). When stratified by the adjustment for potential confounders, we did not shown a significant difference between estimates adjusted and those not adjusted for specific factors (Tables 2-4) .
In a sensitivity analysis, we sequentially removed one study at a time and reanalyzed the data. The 32 study-specific RRs of ever breastfeeding ranged from a low of 0.74 (95% CI: 0.68, 0.80) after omission of the study by Chiaffarino et al (16) to a high of 0.77 (95% CI: 0.71, 0.84) after omission of the study by Gwinn et al (41) . Similar analyses were also carried out in the doseresponse analysis of total breastfeeding duration, with studyspecific RRs ranging from a low of 0.92 (95% CI: 0.89, 0.95) after omission of the study by Chiaffarino et al (16) to a high of 0.93 (95% CI: 0.90, 0.96) after omission of the study by Mills et al (28) .
DISCUSSION
The findings from this meta-analysis of epidemiologic studies indicated that ever breastfeeding had an almost 24% reduction in EOC risk compared with that for never breastfeeding. The risk reduction was similar for borderline and invasive EOC, and was consistently reported in case-control and cohort studies. In addition, results of dose-response analyses suggested that risk of EOC decreased by 8% for each 5-mo increase in total breastfeeding duration.
The inverse association between breastfeeding and risk of borderline EOC as well as invasive EOC is biologically plausible. Recently, 2 hypotheses have dominated when the cause of ovarian pathogenesis has been considered. One of these hypotheses proposes that, because of incessant ovulation, repeated trauma to the ovary caused by ovulation may increase ovarian cancer risk (5) . The other hypothesis suggests that excessive concentrations of gonadotropins increase EOC risk through increased estrogen stimulation, which promotes cell proliferation and increases the opportunity for malignant transformation (8) . Research also has indicated that breastfeeding may reset pregnancy-related changes, possibly through hypothalamic-pituitary-regulated mechanisms that mediate EOC risk (17) . Breastfeeding also causes gonadotrophin suppression, which leads to low estrogen concentration and induces a state of relative quiescence in women's ovaries by suppressing the release of luteinizing hormone and, thereby, preventing ovulation. Thus, according to these hypotheses, ever breastfeeding and a longer duration of breastfeeding would be expected to decrease EOC risk through their effects on ovulation and gonadotropin concentrations. Significant inverse associations for the duration of breastfeeding on EOC risk were only observed in American populations (Tables 3 and 4) , which could have been attributed to a greater variation in breastfeeding patterns and duration. Rosenblatt et al (39) reported that nearly 90% of the study population breastfed for $1 mo in a multinational case-control study, which resulted in a referent group of women who breastfed for 0-4 mo instead of women who never breastfed. However, populations in which more than one-half of the women had never breastfed were observed in several population-based case-control studies in United States (24, 27) . By comparison, Salazar-Martinez et al (35) reported mean breastfeeding duration of 12.7 mo/child in 668 hospital-based controls in Mexico, whereas Mori et al (37) reported a mean breastfeeding duration of 8.5 mo/child in 323 hospital-based controls in Japan.
Although the average duration of breastfeeding per child has more public health applicability than the total duration, only 9 case-control studies (14, 16, 17, 23, 25, 30, 36, 39, 46) reported the results of this average measurement; therefore, we only carried out analyses for the total duration in the main study. Doseresponse results for the average duration of breastfeeding per child (summary RR for a 5-mo increase in duration: 0.91 (95% CI: 0.85, 0.98), which was calculated from 7 (16, 17, 23, 25, 36, 39, 46) of these 9 studies) was similar to the results of the total duration, which also supported our findings. Besides, the majority of included studies adjusted for parity or the number of live births.
Although not all the studies presented results by histologic subtype and cancer grade, our meta-analysis suggested a significant inverse association for breastfeeding with invasive, borderline, serous, and endometrioid EOC. These results were consistent in the dose-response analyses of breastfeeding duration. However, because of the limited number of studies that reported histologic subtypes, the results should be interpreted with caution.
The strengths of this meta-analysis included the large sample size of 14,465 cases and 706,152 noncases. This sample size should have provided sufficient statistical power to detect the putative association between ever breastfeeding and the duration of breastfeeding with risk of EOC. In addition, our study considered a number of subgroups to evaluate heterogeneity. Our study also has several limitations. First, as a meta-analysis of observational studies, it was prone to biases (eg, recall and selection bias) inherent in the original studies. Cohort studies are less susceptible to bias than case-control studies because, in the prospective design, information on exposures is collected before the diagnosis of the disease. Although the results of the metaregression showed no evidence of significant heterogeneity between subgroups, summary association estimates were slightly different in subgroup analyses by study design and exposure assessment. It is possible that the relations reported by case-control studies may have been overstated as a result of recall or interviewer bias. In addition, some recent cohort studies provided detailed information of adjustment for confounders, whereas some early case-control studies adjusted for fewer factors. Thus, more large studies, especially prospective studies, are warranted in the future.
A second limitation was that individual studies may have failed to control for potential confounders, which may have introduce bias in an unpredictable direction. Ever breastfeeding and a longer duration of breastfeeding are often associated with other hormone-dependent or reproductive factors, including lower levels of BMI (64), a lower prevalence of OC use (65), a higher parity number, and a lower prevalence of smoking (66) . Many, but not all, of the studies adjusted for potential confounding factors. However, an inverse association was still observed when we stratified results according to the adjustment for confounding factors, and the evidence of meta-regression analyses indicated that the adjustment for these confounders was not a source of heterogeneity.
Third, significant heterogeneity and a possible publication bias must be considered. There was significant heterogeneity in the pooled analysis of ever breastfeeding (Q = 69.40, P , 0.001, I 2 = 55.3%) and in the dose-response analysis of the total breastfeeding duration (Q = 74.12, P , 0.021, I 2 = 67.6%). Despite the numerous subgroup and sensitivity analyses that were carried out, heterogeneity still existed in our study. To our knowledge, the category of duration of breastfeeding, especially the longest duration, differed between studies and may have contributed to the heterogeneity in results. However, few of the included studies reported how they categorized the duration of breastfeeding, and thus, we hardly considered this point in the subgroup analysis and ruled out the heterogeneity thoroughly. Publication bias can be a problem in meta-analyses of published studies; however, we showed no statistical evidence of a publication bias in the meta-analysis, and there did not appear to be asymmetry in funnel plots when inspected visually.
In conclusion, findings from this meta-analysis suggest that breastfeeding, particularly a longer duration of breastfeeding, was inversely associated with risk of EOC. The results were consistent with benefits of breastfeeding proposed by the US National Institute of Child Health and Human Development (67) and may have implications for women's decisions regarding breastfeeding in the future.
